Deadline: 21-Apr-23
Applications for Small Business Research Initiative (SBRI): Overdose Detection, Response and Intervention Demonstration are now open to develop disruptive, innovative solutions that focus on detecting, responding to, and intervening in, early acute risk of non-fatal and fatal overdose.
Priorities
Projects can focus on one or more of the following priorities:
- discrete digital technology solutions with intuitive and simple design, focussed on service users and responders
- simple alert or responder pathways that create effective responses to potentially fatal overdose events
- enhance the ability to self-monitor by people who use drugs
- improved equity of access, detection and response in this vulnerable population through connected and safe digitalised platforms
- enhanced simple live intelligent data gathering processes, surveillance and remote monitoring
- enhance innovative intervention therapeutics as antidotes to overdose episodes
Themes
Your project can focus on one or more of the following themes:
- detection of potential overdose episodes
- alert or response to potential overdose episodes
- intervention therapeutics as antidotes to overdose episodes
Types of Competitions
- Competition 1 – SBRI: Overdose detection, response and intervention feasibility
- This competition is for feasibility studies for projects which have not yet reached prototype development.
- This is phase 1 of a potential 2 phase competition. The decision to proceed to phase 2 will depend on success in phase 1 and the assessment of a separate application.
- Competition 2 – SBRI: Overdose detection, response and intervention demonstration (this competition)
- This competition is for projects with technology already at an advanced stage of development, and near ready to be deployed in a real-world environment.
- This is a single-phase competition.
Funding Information
Your project can range in size up to total costs of £500,000 inclusive of VAT.
Eligibility Criteria
- Projects must:
- aim to start by 1 August 2023
- end 12 months after the agreed start date
- work in conjunction with a test bed research partner by delivering R&D services to develop a solution
- acquire evidence which will support future product approval and use of innovations across the UK health systems (Wales, Northern Ireland, Scotland and England)
- To lead a project, you can:
- be an organisation of any size, registered in the UK, European Union (EU) and the European Economic Area (EEA)
- work alone or with others from business, research organisations, research and technology organisations or the third sector as subcontractors
Ineligible
They will not fund projects that:
- do not demonstrate significant support and engagement from potential future customers throughout the project
- do not provide a clear route to market
- do not address how any potentially negative outcomes, such as on the environment or society, would be managed
- do not evidence the potential for their proposed innovation to generate positive economic or societal impact
- would directly duplicate other UK government, Scottish government, NHS or EU funded initiatives you have already been funded to deliver
- are covered by existing commercial agreements to deliver the proposed solutions
- do not have the relevant certification and compliance accreditations if the project is already a well-developed prototype
- do not feature a demonstration phase, offering users a chance to use the innovation and give feedback
- do not include an evaluation phase and a plan to collect information to inform a cost or benefit analysis
- do not have a test bed research partner to work with
- do not demonstrate a credible plan for acquiring data which would support product approval in all 4 UK healthcare systems
For more information, visit SBRI.